KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio (2020 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Debt Ratio for 9 consecutive years, with 0.02 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 38.23% to 0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02, a 38.23% decrease, with the full-year FY2025 number at 0.02, down 38.23% from a year prior.
  • Debt Ratio was 0.02 for Q4 2025 at Supernus Pharmaceuticals, up from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.25 in Q4 2021 to a low of 0.01 in Q3 2025.
  • A 5-year average of 0.05 and a median of 0.03 in 2022 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 1464.27% in 2022; the steepest drop was 95.06% in 2022.
  • Supernus Pharmaceuticals' Debt Ratio stood at 0.25 in 2021, then plummeted by 95.06% to 0.01 in 2022, then soared by 228.52% to 0.04 in 2023, then fell by 15.09% to 0.03 in 2024, then crashed by 38.23% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Debt Ratio are 0.02 (Q4 2025), 0.01 (Q3 2025), and 0.02 (Q1 2025).